Candida auris : An emerging multidrug-resistant pathogen | Zendy

David Sears | Zendy; Brian S. Schwartz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Candida auris : An emerging multidrug-resistant pathogen

Author(s) -

David Sears,

Brian S. Schwartz

Publication year - 2017

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2017.08.017

Subject(s) - candida auris , echinocandins , fungal pathogen , multiple drug resistance , pathogen , outbreak , antifungal , medicine , infection control , intensive care medicine , transmission (telecommunications) , microbiology and biotechnology , biology , drug resistance , virology , voriconazole , caspofungin , electrical engineering , engineering

Candida aurisis an emerging multidrug-resistant pathogen that can be difficult to identify using traditional biochemical methods. C. auris is capable of causing invasive fungal infections, particularly among hospitalized patients with significant medical comorbidities. Echinocandins are the empiric drugs of choice for C. auris, although not all isolates are susceptible and resistance may develop on therapy. Nosocomial C. auris outbreaks have been reported in a number of countries and aggressive infection control measures are paramount to stopping transmission.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research